George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here.
No Aether. I think you're mixing us up with the other muppets. I believe they occupy an apartment in the basement of 123 Sesame Street from where they pen their deranged posts on a shared typewriter (with a broken ribbon).
I see Mankowsk'i hire as the company's full-time CMO 3 months ago as the canary in this goldmine. Investors looking for a sign of things to come would view his voluntary move from position of CEO of a top CRO, to join Synairgen, at this critical juncture, as 'somewhat' of a sign. Hiring of a CMO is a time critical affair for Biotechs - hire too early and it doesn't work, too late and you're behind with Regulators, key activities that the CMO is responsible for, etc. So say the various experts in the role. They did not fill that role, at that point, for fun. This is part of an orchestrated plan. Let the naysayers protest, but they cannot disagree that his hiring is significant and bodes of things to come.
Well, they may try, but.........lol.
I see Mankowsk'i hire as the company's full-time CMO 3 months ago as the canary in this goldmine. Investors looking for a sign of things to come would view his voluntary move from position of CEO of a top CRO, to join Synairgen, at this critical juncture, as 'somewhat' of a sign. Hiring of a CMO is a time critical affair for Biotechs - hire too early and it doesn't work, too late and you're behind with Regulators, key activities that the CMO is responsible for, etc. So say the various experts in the role. They did not fill that role, at that point, for fun. This is part of an orchestrated plan. Let the naysayers protest, but they cannot disagree that his hiring is significant and bodes of things to come.
Well, they may try, but.........lol.
Suggest you diarise to come back on 21st March Mani when Winter is officially over, and have your say then, if trials haven't started. Listening to your tedious "they've missed the boat" narrative Before we even reach the point of Winter's close is boring me, and probably everyone else too.
Excellent wpa, one of your finest to date.
Funny how you refer to this investment as mine, and not YOURS? What an odd thing for a so-called fellow investor to say? Are you not invested too then? Or was that some slip?
To your other point, I am interested in the facts as they pertain to my investment here. You shouldn't expect anything less of an investment forum. Even a feral cat has enough intelligence to understand the relationship between increasing rates of disease/hospitalisations and the impact/opportunity or threat that poses to our clinical testing plans in the near term, and development path in the longer term. I can see the mention of C19 now triggers you, but you need to look beyond that - hospitalisations are also being driven by RSV, flu and other respiratory viruses, as I stated below. You need to come from under that rock of yours and embrace reality, if you don't mind me saying Doc.Dan.
"U.S. Still Recording 1,500 COVID Deaths Each Week as Cases Surge Around the Globe
HEADLINEJAN 11, 2024"
https://www.democracynow.org/2024/1/11/headlines/us_still_recording_1_500_covid_deaths_each_week_as_cases_surge_around_the_globe
Posting this current headline from the US as I know Mani and Doc.Dan are very worried about a waning trialling window, but the data would seem to indicate that they should just calm down, no fear of it all suddenly going away and robbing up of our clinical studying opportunities. Hospitalisation cases are rising. Around the globe. As expected with the number of respiratory viruses circulating. Chillax ladies, chillax.
DocDan lives in a parallel universe where Covid is rapidly fading away and current variants are so weak as to barely affect most people. He cannot fathom therefore why hospitalisations due to Covid and other respiratory viruses like flu and rsv ARE RISING. A total head scratcher for our resident Dr!! He forgets that we are not targeting the healthy, nor are we silly enough to think that that who do end up in hospital (largely the immunocompromised, elderly and those who are more genetically more predisposed to the wrath of viruses than the general population) make up a small number. Over 10 million people in Britain alone are categorised as "elderly", i.e. 65 or over. Then there's the immunocompromised, the people affected by the autoabs findings, etc etc. It's not hard to understand why hospitalisations are rising in respiratory virus season. I don't think I need to labour the point for most intelligent readers on here, but Dr. Daneeka, if you are reading this, today's lesson is for you.
Mani only gets paid a bonus people can be convinced to sell. What a joker.
And for Mani who has trouble comprehending the official data ..... "Weekly admissions also increased in the seven days up to 5 January with 3,984 people admitted compared to 3,731 – a 7 per cent increase."
Https://www.independent.co.uk/news/health/covid-cases-variant-juno-schools-latest-b2477113.html
"Rapid rise of global ‘Juno’ variant infections is yet another reminder ‘pandemic is far from over’, warns virologist"
Costas, do behave. Amazon started off as an online bookstore selling books. No telephone number. Just a keyboard and mouse.
Go one, give a like if you're a REAL investor here.
Let's see how many there are on this forum.
Lol.
All IMHO.
Mani,
If I knew the manufacture date of SNG001 drug, rest assured, you and your chums would be the last people I'd share that info with.
I think LBC (or you) are telling porkies there Mani.
According to the latest official stats on UK Gov website "in week 52, influenza activity increased across most indicators, including hospital admissions. COVID-19 activity showed mixed activity, with stabilisation of test positivity rates and reported acute respiratory outbreaks, but slight increases in hospital and intensive care unit (ICU) or high
dependency unit (HDU) admissions. Respiratory syncytial virus (RSV) activity decreased in children aged under 5 years, while RSV hospital admissions increased in older adult groups."
Similarly, in the USA, In the last week of 2023 — through December 30 — there were nearly 35,000 new Covid-19 admissions and more than 20,000 new admissions for flu, according to CDC data.
I believe we are planning some studies in the US as well as UK, maybe someone could confirm?
Agree there Size82. I remain of the opinion that this is an all or nothing share. By 'all' I mean blockbuster - it will either meet a longstanding and costly global unmet clinical need, or it won't. That potential has not changed. There are many strings to the bows of research that are starting to come together. Few are reported on this forum, that does not negate their existence. 100p? I wouldn't dust off a petri dish for 100p if SNG001 is shown to BP to have blockbuster potential. Only time will tell.
Very interesting, I had no idea they were initially discounted as having "no pathological consequences"... Thank goodness people persist and challenge. Thanks for posting Brand.
Axe has been a self-confessed shorter of this stock for a long time, not much else to add really.
Yelps a lot, like Mani and the other yelpers.
Manicure, are you typing on an Olivetti typewriter with a shredded ribbon, because it sure looks like it?
But do carry on.....